Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Wolfe Research Downgrades ArcBest to Peer Perform

Wolfe Research analyst Scott Group downgrades ArcBest (NASDAQ:ARCB) from Outperform to Peer Perform.

byBenzinga Newsdesk

June 4, 2021

1 minute read

Wolfe Research analyst Scott Group downgrades ArcBest (NASDAQ:ARCB) from Outperform to Peer Perform.

Morgan Stanley Maintains Equal-Weight on Phillips 66, Raises Price Target to $105

By Benzinga Newsdesk

Today, 12:14 PM

Morgan Stanley analyst Connor Lynagh maintains Phillips 66 (NYSE:PSX) with a Equal-Weight and raises the price target from $100 to $105.

PSX

Verastem Oncology Q3 EPS $(0.07) Down From $0.11 YoY

By Benzinga Newsdesk

Today, 12:14 PM

Verastem Oncology (NASDAQ:VSTM) reported quarterly losses of $(0.07) per share. This is a 163.64 percent decrease over earnings of $0.11 per share from the same period last year.

VSTM

News

SEC Report Shows Staff To Potentially Study 4 Areas (Areas Listed In Body Of This Headline)

By Benzinga Newsdesk

Today, 12:14 PM

"The Report concludes with the staff identifying areas of market structure and our regulatory framework for potential study and additional consideration. These include: Forces that may cause a brokerage to

SPY

Bitcoin Spikes Above $21,000: Is The Move Sustainable Or Just Speculative Mania?

By Murtuza Merchant

Today, 12:14 PM

The largest cryptocurrency by market capitalization, Bitcoin (CRYPTO: BTC) has spiked above the psychologically important barrier of the $21,000 mark.

$ADA

Wolfe Research Downgrades ArcBest to Peer Perform

Related Posts

Morgan Stanley Maintains Equal-Weight on Phillips 66, Raises Price Target to $105

Verastem Oncology Q3 EPS $(0.07) Down From $0.11 YoY

SEC Report Shows Staff To Potentially Study 4 Areas (Areas Listed In Body Of This Headline)

Bitcoin Spikes Above $21,000: Is The Move Sustainable Or Just Speculative Mania?